Edition:
India

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

63.66USD
1:30am IST
Change (% chg)

$4.56 (+7.72%)
Prev Close
$59.10
Open
$59.83
Day's High
$63.66
Day's Low
$58.88
Volume
17,035
Avg. Vol
34,686
52-wk High
$76.98
52-wk Low
$31.56

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.02 -0.547
Mar '18 0.03 -1.069
FY 2017 Dec '17 0.28 -0.925
Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.26 1.14 0.00 0.77
Quarter Ending Mar-19 1 0.00 0.00 0.00 0.40
Year Ending Dec-18 7 1.20 5.00 0.00 2.57
Year Ending Dec-19 6 1.78 10.00 0.00 2.17
Earnings (per share)
Quarter Ending Dec-18 6 -1.13 -0.80 -1.30 -0.68
Quarter Ending Mar-19 1 -0.97 -0.97 -0.97 -0.80
Year Ending Dec-18 7 -3.72 -3.09 -4.13 -2.71
Year Ending Dec-19 6 -3.98 -1.35 -5.29 -3.20
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -43.26 -39.12 --
EPS (TTM) % -86.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.98 21.63 86 --
13 Week 27.10 20.91 79 --
26 Week 30.62 20.69 76 --
52 Week 78.77 51.52 85 --
YTD 76.83 55.29 81 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.76%
# of Holders: 120
Total Shares Held: 39,648,363
3 Mo. Net Change: -95,240
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 7
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.